|
Values
|
OS (−)
|
OS (+)
|
Statistic(χ2)
|
P-value
|
|---|
|
N
|
34
|
18
| | |
|
Platelet
| | |
4.294
|
0.039
|
|
Increase
|
9(26.5%)
|
10(55.6%)
| | |
|
Decrease
|
25(73.5%)
|
8(44.4%)
| | |
|
D-dimer
| | |
1.353
|
0.337
|
|
Increase
|
8(23.5%)
|
7(38.9%)
| | |
|
Decrease
|
26(76.5%)
|
11(61.1%)
| | |
|
Gender
| | |
8.497
|
0.008
|
|
Male
|
12(35.3%)
|
14(77.8%)
| | |
|
Female
|
22(64.7%)
|
4(22.2%)
| | |
|
Age
| | |
3.059
|
0.072
|
|
≥ 62.5
|
14(41.2%)
|
12(66.7%)
| | |
|
< 62.5
|
20(58.8%)
|
6(33.3%)
| | |
|
Smoking
| | |
6.540
|
0.013
|
|
Past/current
|
27(79.4%)
|
8(44.4%)
| | |
|
Never
|
7(20.6%)
|
10(55.6%)
| | |
|
Exon21
| | |
0.575
|
0.519
|
|
No
|
26(76.5%)
|
12(66.7%)
| | |
|
Yes
|
8(23.5%)
|
6(33.3%)
| | |
|
Exon19
| | |
0.001
|
0.605
|
|
No
|
19(55.9%)
|
10(55.6%)
| | |
|
Yes
|
15(44.1%)
|
8(44.4%)
| | |
|
Other diseases
| | |
5.967
|
0.016
|
|
No
|
25(73.5%)
|
7(38.9%)
| | |
|
Yes
|
9(26.5%)
|
11(61.1%)
| | |
|
Other treatment
| | |
1.549
|
0.172
|
|
No
|
11(32.4%)
|
9(50%)
| | |
|
Yes
|
23(67.6%)
|
9(50%)
| | |
- OS overall survival, OS (−) survival group, OS (+) death group
